Karissa Lorraine Gable

Associate Professor of Neurology

Neurology, Neuromuscular Disease

DUMC 3909, Durham, NC 27710

More About This Person

At a Glance

Credentials
1. Education
2. Training & Certifications

Academic Experience
1. Current Appointments & Affiliations
2. Previous Appointments & Affiliations

Expertise

Research
1. Selected Grants
2. External Relationships

Publications
1. Selected Publications

Artistic Works / Events

Teaching
1. Recent Courses

Advising & Mentoring

Recognition

Professional Activities

Embed Profile Data

Embed Profile Data

Selected Grants

Inflammatory Neuropathy Consortium data Base (INCBase): A prospective international CIDP registry

ResearchPrincipal Investigator · Awarded by University of Minnesota · 2022 - 2026

Open Label Extension study of Rozanolixizumab in CIDP

Clinical TrialPrincipal Investigator · Awarded by UCB Biopharma SPRL · 2020 - 2022

A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (ADHERE)

Clinical TrialPrincipal Investigator · Awarded by Argenex BVBA · 2020 - 2022

Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2021 - 2022

Electrical Impedance Myography and Muscle Ultrasound: Longitudinal Measures in Pompe Disease

Clinical TrialInvestigator · Awarded by Genzyme Corporation · 2016 - 2021

MultiCenter, Randomized, Double-Blind study of Rozanolixizumab in Subjects with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Clinical TrialPrincipal Investigator · Awarded by UCB Biopharma SPRL · 2020 - 2021

Pathogenic Th17 cell pathology in CIDP

ResearchPrincipal Investigator · Awarded by GBS/CIDP Foundation International · 2019 - 2021

Mechanisms of Immune Dysregulation in Chronic Inflammatory Demyelinating Polyneuropathy

FellowshipPI-Fellow · Awarded by AANEM Foundation for Research & Education · 2019 - 2020

Exploratory Study of BioMarkers Predicting Response to Immunosuppressives in Myasthenia Gravis

Clinical TrialPrincipal Investigator · Awarded by Duke Clinical Research Institute · 2015 - 2020

Role of CD4 T Cell subsets as drivers of MG Diseases -EPM 6568

ResearchPrincipal Investigator · Awarded by Myasthenia Gravis Foundation · 2018 - 2019

External Relationships

AANEM
Accordant Health Services
Adivo Associates
AstraZeneca
CSL Behring LLC

Grifols

Guidepoint

Immunovant

KeyQuest Health

MarketPlus

Medscape ( WebMD HLTH Corp.)

Reach MD

Sanofi

TECHSPERT

Takeda Pharmaceutical Co. Ltd.

argenx US, Inc

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.